Research programme: gastrin inhibitors - Cancer AdvancesAlternative Names: Gastrin monoclonal antibody; Progastrin inhibitor; Progastrin monoclonal antibody
Latest Information Update: 19 Sep 2013
At a glance
- Originator Cancer Advances
- Class Monoclonal antibodies
- Mechanism of Action Gastrin inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 15 Jul 2013 Early research in Cancer in USA (unspecified route)